Skip to main content
logo
Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.450
+0.010 (0.69%)
At close: Sep 4, 2025, 4:00 PM
1.450
0.00 (0.00%)
Pre-market: Sep 5, 2025, 8:47 AM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Chimeric Antigen Receptors T Cell Therapies
10.12M
Log In
Log In
Log In
Log In
Upgrade
Chimeric Antigen Receptors T Cell Therapies Growth
496.00%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Europe
10.12M
Log In
Log In
Log In
Log In
Upgrade
United States
-
Log In
Log In
Log In
Log In
Upgrade
United Kingdom
-
Log In
Log In
Log In
Log In
Upgrade
United Kingdom, Europe and United States
-
Log In
Log In
Log In
Log In
Upgrade
United Kingdom, Europe and United States Growth
-
Log In
Log In
Log In
Log In
Upgrade